Topper James N
SEC CIK 1341382 · EDGAR
BoughtSold
Most active insiders at PHAT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Breedlove Robert Charles | Principal Accounting Off | — | $7,079 |
| 2 | Narula Sanjeev | Chief Financial, Bus. Off | — | — |
| 3 | Parikh Asit | Dir | — | — |
| 4 | Stenhouse Mark | Dir | — | — |
| 5 | Basta Steven L | Pres, CEO, Dir | — | — |
| 6 | Schroeder Theodore R | Dir | — | — |
| 7 | Topper James N | Dir, 10% | — | — |
| 8 | Cook Anne Marie | Chief Legal Off, Corp. Sec | — | — |
| 9 | KARBE FRANK | Dir | — | — |
| 10 | COLA MICHAEL F | Dir | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:30 | 2026-05-19 | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir, 10% | A - Grant | $0.00 | +24.1K | 66.7K | +57% | $0 | |
| I | 2025-09-17 | 2025-09-15 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $23.70 | +660 | 3.03M | +0.0% | +$15.6K |
| I | 2025-09-10 | 2025-09-08 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $24.99 | +1,260 | 3.03M | +0.0% | +$31.5K |
| I | 2025-08-13 | 2025-08-11 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $23.98 | +471 | 3.03M | +0.0% | +$11.3K |
| MI | 2025-06-26 | 2025-06-24+ | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $18.37 | +3,780 | 3.03M | +0.1% | +$69.5K |
| I | 2025-06-18 | 2025-06-16 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $19.50 | +8,584 | 3.02M | +0.3% | +$167.4K |
| D | 2025-06-05 | 2025-06-03 | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir, 10% | A - Grant | $0.00 | +10.5K | 42.6K | +33% | $0 |
| I | 2025-05-23 | 2025-05-21 | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir | P - Purchase | $3.86 | +3,780 | 59.4K | +7% | +$14.6K |
| MI | 2025-05-15 | 2025-05-13+ | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir | P - Purchase | $3.30 | +7,420 | 55.6K | +15% | +$24.5K |
| MI | 2025-05-13 | 2025-05-09+ | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir | P - Purchase | $3.17 | +48.2K | 33.4K | New | +$152.8K |
| I | 2025-03-28 | 2025-03-26 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $22.49 | +1,135 | 3.01M | +0.0% | +$25.5K |
| I | 2025-03-06 | 2025-03-04 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $21.02 | +4,005 | 3.01M | +0.1% | +$84.2K |
| D | 2024-05-24 | 2024-05-23 | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir, 10% | A - Grant | $0.00 | +10.5K | 32.1K | +49% | $0 |
| I | 2024-03-28 | 2024-03-26 | NAMS | NewAmsterdam Pharma Co N.V. | Topper James N | Dir | P - Purchase | $21.50 | +8,429 | 3.01M | +0.3% | +$181.2K |
| D | 2023-05-30 | 2023-05-25 | PHAT | Phathom Pharmaceuticals, Inc. | Topper James N | Dir, 10% | A - Grant | $0.00 | +9,000 | 21.6K | +71% | $0 |
Purchase Sale Sale after option exercise All abbreviations